NEW YORK, N.Y., April 30 - Pfizer Inc. (NYSE:PFE) today announced that Dawn Rogers will become Executive Vice President of Worldwide Human Resources, effective June 1, 2018. She is currently Senior Vice President of Human Resources for the Chief Operating Officer, Albert Bourla. Ms. Rogers will report directly to Chairman and CEO Ian Read and join Pfizer’s Executive Leadership team.
Meridian, a subsidiary of Pfizer that manufactures EpiPen auto-injectors, has experienced intermittent constraints affecting U.S. supply. The U.S. Food and Drug Administration (FDA) has posted a supply notification on its website about EpiPen® (epinephrine injection, USP) 0.3 mg and EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors, and the authorized generic versions of these strengths, to provide greater transparency and confirm that the product remains available.
NEW YORK, N.Y., May 24 – Pfizer Inc. today announced that it has reached a settlement agreement with the federal government to resolve civil claims relating to certain financial donations made by the Company to independent charity patient assistance programs prior to 2017. Under the agreement, Pfizer will make a payment of $23.85 million to the government to resolve these claims.
FOR IMMEDIATE RELEASE-LAKE FOREST, IL., June 4, 2018 - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69), to the hospital/institution level due to the potential presence of embedded and loose particulate matter on the syringe plunger.
NEW YORK, NY, September 17, 2019 - Football legend Terry Bradshaw and Pfizer are partnering for a second year on the All About Your Boom™ campaign with the goal of educating Baby Boomers about the risk for pneumococcal pneumonia. The campaign encourages adults aged 65 or older to speak with their healthcare provider about whether vaccination to help prevent pneumococcal pneumonia is right for them.
New York, NY, Tuesday, September 17, 2019 – 08:03 am EDT
NEW YORK, N.Y., October 17, 2019 – Pfizer Inc. (NYSE:PFE) stated today that a recognized compensation expert confirmed equitable pay practices at Pfizer, after accounting for employee role, education, experience, performance, and location and without regard to gender or race.
NEW YORK, N.Y., November 15, 2019 – Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a final opinion following the re-evaluation of the benefit/risk of the three approved indications of XELJANZ in the European Union (Article 20 procedure).
Pfizer will become the first company to bring three oncology monoclonal antibody (mAb) biosimilar treatments to the U.S. market
NEW YORK, March 2, 2020—Pfizer Inc. (NYSE: PFE) announced that today Pfizer’s Chief Scientific Officer Mikael Dolsten participated in a meeting with other pharmaceutical companies about various ways to develop vaccines and therapeutics for COVID-19 held at the White House.
Pfizer was pleased to have been part of the important meeting convened by the President, given the company’s leading research expertise, manufacturing capability and capacity, and regulatory experience, to help combat the virus.